The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20082074
The Journal of Experimental Medicine, Vol. 206, No. 9, 1957-1970
The Rockefeller University Press, 0022-1007 $30.00
© Grundler et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 5488K)
Right arrow PDF+supp data (11052K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Grundler, R.
Right arrow Articles by Schwaller, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grundler, R.
Right arrow Articles by Schwaller, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration

Rebekka Grundler1, Laurent Brault2, Christelle Gasser2, Alex N. Bullock3, Tobias Dechow1, Sabine Woetzel1, Vanda Pogacic2, Antonello Villa4, Sabine Ehret2, Georgina Berridge3, Anke Spoo5, Christine Dierks5, Andrea Biondi4, Stefan Knapp3, Justus Duyster1, and Juerg Schwaller2

1 Department of Internal Medicine III, Technical University, Munich 81739, Germany
2 Department of Biomedicine, University Hospital, Basel 4031, Switzerland
3 University of Oxford, Structural Genomics Consortium, Old Road Campus Research Centre, Oxford OX3 7DQ, England, UK
4 Centro M. Tettamanti-Clinica Pediatrica, Universita Milano-Bicocca, 20042 Monza, Italy
5 Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg 79111, Germany

CORRESPONDENCE Juerg Schwaller: J.Schwaller{at}unibas.ch OR Justus Duyster: Justus.Duyster{at}lrz.tum.de

FLT3-ITD–mediated leukemogenesis is associated with increased expression of oncogenic PIM serine/threonine kinases. To dissect their role in FLT3-ITD–mediated transformation, we performed bone marrow reconstitution assays. Unexpectedly, FLT3-ITD cells deficient for PIM1 failed to reconstitute lethally irradiated recipients, whereas lack of PIM2 induction did not interfere with FLT3-ITD–induced disease. PIM1-deficient bone marrow showed defects in homing and migration and displayed decreased surface CXCR4 expression and impaired CXCL12–CXCR4 signaling. Through small interfering RNA–mediated knockdown, chemical inhibition, expression of a dominant-negative mutant, and/or reexpression in knockout cells, we found PIM1 activity to be essential for proper CXCR4 surface expression and migration of cells toward a CXCL12 gradient. Purified PIM1 led to the phosphorylation of serine 339 in the CXCR4 intracellular domain in vitro, a site known to be essential for normal receptor recycling. In primary leukemic blasts, high levels of surface CXCR4 were associated with increased PIM1 expression, and this could be significantly reduced by a small molecule PIM inhibitor in some patients. Our data suggest that PIM1 activity is important for homing and migration of hematopoietic cells through modification of CXCR4. Because CXCR4 also regulates homing and maintenance of cancer stem cells, PIM1 inhibitors may exert their antitumor effects in part by interfering with interactions with the microenvironment.


J. Duyster and J. Schwaller contributed equally to this paper.

Abbreviations used: AML, acute myeloid leukemia; HSC, hematopoietic stem cell; mRNA, messenger RNA; PTK, protein tyrosine kinase; siRNA, small interfering RNA.

© 2009 Grundler et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS